Memantine for patients with Alzheimer disease.
Finucane
Thomas E
TE
D000544:Alzheimer Disease / Q000188:drug therapy*; D017028:Caregivers; D002800:Cholinesterase Inhibitors; D003362:Cost-Benefit Analysis; D000077265:Donepezil; D015259:Dopamine Agents / Q000627:therapeutic use*; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008559:Memantine / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D011788:Quality of Life
D002800:Cholinesterase Inhibitors; D015259:Dopamine Agents; D018691:Excitatory Amino Acid Antagonists; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil; D008559:Memantine